Select Publications

Arriagada R et al; International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung
cancer. N Engl J Med 2004;350(4):351-60. Abstract

Douillard JY et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial.
Lancet Oncol 2006;7(9):719-27. Abstract

Douillard J et al. ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association. Proc ASCO 2005;Abstract 7013.

Fossella F et al. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group. J Clin Oncol 2003;21(16):3016-24. Abstract

Groen HJ et al. A phase II study of erlotinib (E) and bevacizumab (B) in patients (pts) with previously untreated stage IIIB/IV non-small cell lung cancer (NSCLC). Proc ASCO 2007;Abstract 7625.

Hanna NH et al. Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients with inoperable
stage III non-small cell lung cancer (NSCLC): HOG LUN 01-24/USO-023. Proc ASCO 2007;Abstract 7512.

Herbst RS et al. Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment
of recurrent or refractory non small-cell lung cancer. J Clin Oncol 2007;25(30):4743-50. Abstract

Herbst RS et al. Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non small-cell lung cancer. J Clin Oncol 2005;23(11):2544-55. Abstract

Scagliotti GV et al. A randomized phase III trial of cisplatin and pemetrexed versus cisplatin and gemcitabine in patients with locally advanced or metastatic non-small cell lung cancer. Proc 12th World Conference on Lung Cancer 2007;Abstract PRS-03.

Winton T et al. Vinorelbine plus cisplatin vs observation in resected non–small-cell lung cancer. N Engl J Med 2005;352:2589-97. Abstract

Home

EDITOR
Neil Love, MD

INTERVIEWS
Paul A Bunn Jr, MD
- Select publications

Nasser H Hanna, MD
- Select publications

Antoinette J Wozniak, MD
- Select publications

A CME Audio Series and Activity

Faculty Disclosures

Editor's Office